XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ (291,713) $ (11,885)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation, depletion, amortization and accretion expense 906,763 836,057
Impairment of oil and natural gas properties 284,090 0
Amortization of deferred financing costs and original issue discount 6,595 6,930
Equity-based compensation expense 13,499 8,859
Price risk management activities (income) expense (75,228) (41,531)
Net cash received (paid) on settled derivative instruments 55,087 (14,941)
Equity method investment (income) expense 37 9,054
Loss (gain) on extinguishment of debt 0 60,256
Settlement of asset retirement obligations (90,078) (86,074)
Loss (gain) on sale of assets 210 (10,069)
Loss (gain) on sale of business 0 (100,482)
Changes in operating assets and liabilities:    
Accounts receivable 71,726 24,183
Other current assets 7,878 (34,649)
Accounts payable (27,467) 12,624
Other current liabilities (67,146) (41,246)
Other non-current assets and liabilities, net (60,207) (3,830)
Net cash provided by (used in) operating activities 734,046 613,256
Cash flows from investing activities:    
Exploration, development and other capital expenditures (361,637) (355,197)
Cash acquired in excess of payments for acquisitions 1,690 0
Payments for acquisitions, net of cash acquired (43,939) (936,214)
Proceeds from (cash paid for) sale of property and equipment, net 1,195 1,017
Contributions to equity method investees (1,996) (19,627)
Proceeds from sales of businesses 0 141,997
Net cash provided by (used in) investing activities (404,687) (1,168,024)
Cash flows from financing activities:    
Issuance of common stock 0 387,717
Issuance of senior notes 0 1,250,000
Redemption of senior notes 0 (897,116)
Proceeds from Bank Credit Facility 0 820,000
Repayment of Bank Credit Facility 0 (895,000)
Deferred financing costs 0 (29,886)
Other deferred payments (12,969) (1,791)
Payments of finance lease (14,544) (13,238)
Purchase of treasury stock (103,003) (45,181)
Employee stock awards tax withholdings (3,519) (5,791)
Distribution to noncontrolling interest (1,347) 0
Net cash provided by (used in) financing activities (135,382) 569,714
Net increase (decrease) in cash, cash equivalents and restricted cash 193,977 14,946
Cash, cash equivalents and restricted cash:    
Balance, beginning of period 214,432 135,999
Balance, end of period 408,409 150,945
Supplemental non-cash transactions:    
Capital expenditures included in accounts payable and accrued liabilities 70,337 110,201
Supplemental cash flow information:    
Interest paid, net of amounts capitalized $ 117,832 $ 127,367